antiviral drug

Pharma

Roche signs generic Xofluza licensing deal with MPP

Under the Roche deal, MPP is seeking applications from generic makers that have the capacity to support the development and supply of generic Xofluza.

Angus Liu May 19, 2026 11:15am

An envelope with rejected mark Vector illustration

Manufacturing issues prompt FDA rejection of Hyloris antiviral

Mar 13, 2026 8:40am

Fierce Biotech

Study finds HIV can evolve to resist lenacapavir—at a cost

Jan 7, 2026 2:00pm

An artists concept of different strains or types of coronaviruses shown in multiple bright colors against a teal background

Shionogi's antiviral comes up short in global COVID-19 trial

May 13, 2024 10:48am

Pfizer's Paxlovid access questioned ahead of WTO patent talks

Nov 21, 2022 11:41am

FDA swats away Gilead's hepatitis D treatment bulevirtide

Oct 28, 2022 9:52am